RESUMO
A polymorphism consisting of the presence or absence of a 250-bp DNA fragment was detected within the angiotensin I-converting enzyme gene (ACE) using the endothelial ACE cDNA probe. This polymorphism was used as a marker genotype in a study involving 80 healthy subjects, whose serum ACE levels were concomitantly measured. Allele frequencies were 0.6 for the shorter allele and 0.4 for the longer allele. A marked difference in serum ACE levels was observed between subjects in each of the three ACE genotype classes. Serum immunoreactive ACE concentrations were, respectively, 299.3 +/- 49, 392.6 +/- 66.8, and 494.1 +/- 88.3 micrograms/liter, for homozygotes with the longer allele (n = 14), and heterozygotes (n = 37) and homozygotes (n = 29) with the shorter allele. The insertion/deletion polymorphism accounted for 47% of the total phenotypic variance of serum ACE, showing that the ACE gene locus is the major locus that determines serum ACE concentration. Concomitant determination of the ACE genotype will improve discrimination between normal and abnormal serum ACE values by allowing comparison with a more appropriate reference interval.
Assuntos
Peptidil Dipeptidase A/genética , Polimorfismo Genético , Adulto , Deleção Cromossômica , DNA/análise , Elementos de DNA Transponíveis , Feminino , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Peptidil Dipeptidase A/sangue , Polimorfismo de Fragmento de RestriçãoRESUMO
Studies of the response of p53-lacZ transgenic mice have uncovered an unexpected induction of endogenous acid-beta-galactosidase activity following whole body irradiation. Strong induction of endogenous enzyme activity is seen in a variety of mouse strains commonly used in the production of transgenes. The induction of endogenous enzyme activity therefore complicates the analysis of p53-lacZ transgenes and may also influence the analysis of radiation responses in other lacZ-reporter mice.
Assuntos
Artefatos , Proteínas de Escherichia coli/biossíntese , Genes Reporter , Genes Sintéticos , Genes p53 , Óperon Lac , Lisossomos/enzimologia , Proteínas Recombinantes de Fusão/análise , Proteínas Recombinantes de Fusão/biossíntese , Transgenes , Irradiação Corporal Total , beta-Galactosidase/biossíntese , Animais , Soluções Tampão , Indução Enzimática/efeitos da radiação , Proteínas de Escherichia coli/análise , Proteínas de Escherichia coli/genética , Reações Falso-Positivas , Concentração de Íons de Hidrogênio , Ativação de Macrófagos/efeitos da radiação , Macrófagos/enzimologia , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos CBA , Camundongos Transgênicos , Fagocitose , Glândulas Salivares/enzimologia , Especificidade da Espécie , Baço/enzimologia , Proteína Supressora de Tumor p53/biossíntese , beta-Galactosidase/análise , beta-Galactosidase/genéticaRESUMO
The G(M2) activator protein is a substrate specific cofactor for degradation of G(M2) ganglioside by lysosomal beta-hexosaminidase A. Mutations in the gene encoding the activator result in the AB-variant form of G(M2) gangliosidosis. The activator protein contains at least three functional elements; a hydrophobic binding pocket, an oligosaccharide binding site(s), and an area that interacts with hexosaminidase A. In this report a fluorescence dequenching assay specific for only the hydrophobic binding pocket is evaluated and optimized. It is shown that various glycolipids inhibit the transport between liposomes of a self-quenching fluorescent lipid probe, octadecylrhodamine, by the activator protein. The level of inhibition produced by each glycolipid is then used to characterize the oligosaccharide-binding specificity of the activator. The fluorescence dequenching assay is also used to evaluate the functionality of a truncated form of the activator protein. Our results indicate that this simple assay can be used to determine structure-function relationships within the normal or mutant forms of the activator. The data suggest that the C-terminus of the activator is required to produce a functional hydrophobic binding pocket.
Assuntos
Gangliosídeo G(M2)/metabolismo , Glicolipídeos/metabolismo , Proteínas/metabolismo , Sítios de Ligação , Sequência de Carboidratos , Clonagem Molecular , Escherichia coli/genética , Fluorescência , Proteína Ativadora de G(M2) , Hexosaminidase A , Dados de Sequência Molecular , Oligossacarídeos/química , Reação em Cadeia da Polimerase , Proteínas/química , Proteínas/genética , Relação Estrutura-Atividade , beta-N-Acetil-Hexosaminidases/metabolismoRESUMO
CBA mouse strains have been used for many years as a model of radiation-induced acute myeloid leukaemia and the leukaemias in CBA and their F1 hybrids are characterised by a specific loss of heterozygosity involving one homologue of chromosome 2. Previous cytogenetic studies of transplanted irradiated bone marrow, or of bone marrow obtained from irradiated mice significantly before the appearance of leukaemia, have been interpreted as the chromosome 2 deletion being a high frequency, possibly initiating event. However, these studies had not specifically addressed the question of whether the characteristic deletion was induced at a high frequency in stem cells. Using a PCR-based technique, we have studied the induction of chromosome 2 LOH in the progeny of (CBA/H x C57BL/6)F1 stem cells after a potentially leukaemogenic radiation exposure. Whilst chromosome 2 LOH can be induced directly by irradiation and there is a preferential loss of the CBA allele, the frequency is no greater than LOH induced in other chromosomal regions studied. The data do not support radiation-induced deletion involving one homologue of chromosome 2 in long-term repopulating stem cells (<1 in 200) being as high a frequency event as might be inferred by previous cytogenetic studies of total bone marrow.
Assuntos
Células-Tronco Hematopoéticas/efeitos da radiação , Perda de Heterozigosidade/efeitos da radiação , Animais , Células da Medula Óssea/efeitos da radiação , Transplante de Medula Óssea , Cromossomos/efeitos da radiação , Células Clonais/patologia , Células Clonais/ultraestrutura , Leucemia Induzida por Radiação/etiologia , Leucemia Induzida por Radiação/genética , Camundongos , Camundongos Endogâmicos CBA , Repetições de Microssatélites , Reação em Cadeia da Polimerase/métodosRESUMO
A prospective study was conducted to compare the frequency of renin gene polymorphisms in normotensive and hypertensive subjects. Hypertensive (n = 102, blood pressure 168 +/- 17/103 +/- 9 mm Hg) and normotensive (n = 120, blood pressure 122 +/- 10/75 +/- 9 mm Hg) subjects were white, had similar age and sex distributions (hypertensive group, 45 +/- 10 years old and 52% female; normotensive group, 44 +/- 9 years old and 55% female) and similar body mass index (hypertensive group, 23.2 +/- 2.6; normotensive group, 22.5 +/- 2.4 kg/m2, p = 0.048). The familial susceptibility to hypertension was defined as at least one parent and one sibling who were hypertensive before age 65; subjects in the normotensive group had no familial history of hypertension. Renin gene polymorphisms located throughout the renin gene were identified by using three restriction enzymes (Taq I, HinfI, HindIII). For each polymorphic restriction site, allele frequencies were similar in the hypertensive and the normotensive groups. In the absence of parental genotypes, the haplotype frequencies combining the three restriction fragment length polymorphisms were estimated by using maximum likelihood techniques and were similar in both groups (hypertensive group, 0.429, 0.277, and 0.177; normotensive group, 0.453, 0.245, and 0.195 for the three most common haplotypes). A rare haplotype detected by Taq I/Hind III was apparently more frequent in the hypertensive than in the normotensive group (hypertensive group, tH 0.086, th 0.022; normotensive group, tH 0.038, th 0.050), but the difference was not statistically significant. In conclusion, no association between renin gene polymorphisms and essential hypertension was demonstrated in the present study.
Assuntos
Hipertensão/genética , Polimorfismo de Fragmento de Restrição , Renina/genética , Adulto , Alelos , Ligação Genética , Genótipo , Haplótipos , Humanos , Pessoa de Meia-Idade , Valores de ReferênciaRESUMO
The authors describe a manual method for the direct assay of iron in human serum using the ammonium salt of Chromazurol B. This new chromogen reacts with ferric or ferrous ions and cetyltrimethylammonium bromide giving a purple ternary complex. Reliability and practicability of the method are studied. The results correlate very well either with those of the SFBC's method or with a direct ferrozine-guanidine kit. The reagents are very cheap, the method is quickly performed; no significant interference could be observed in case of high concentrations of added bilirubin, copper or hemoglobin.
Assuntos
Benzoatos , Compostos Cromogênicos , Ferro/sangue , Humanos , EspectrofotometriaRESUMO
The GM2 activator protein is a small monomeric protein containing a single site for Asn-linked glycosylation. Its only proven in vivo function is to act as a substrate specific cofactor for the hydrolysis of GM2 ganglioside by lysosomal beta-hexosaminidase A. However, we and others have shown it can act as a general glycolipid transporter at neutral pH in vitro. Any other possible in vivo functions would require that some of the newly synthesized activator molecules not be targeted to the lysosome. The lysosomal targeting mechanism for the activator has not been conclusively identified. While earlier reports suggested that it is likely through the mannose-6-phosphate receptor, another more recent report demonstrated that deficient human cells could recapture nonglycosylated, bacterially produced activator, suggesting its use of an alternate targeting pathway. Here, we demonstrate that the mannose-6-phosphate pathway is likely the major intracellular, biosynthetic route to the lysosome, as well as a high affinity recapture pathway for the endocytosis of activator protein from extracellular fluids. Additionally, we show that there exists a second lower affinity recapture pathway that requires its native protein structure, is carbohydrate independent, and likely does not involve its ability to bind glycosphingolipids in the plasma membrane. Finally, we document that the pool of newly synthesized precursor activator protein contains a majority of molecules with a complex-type oligosaccharide, which cannot contain a functional mannose-6-phosphate targeting signal. These molecules makeup the secreted forms of the protein in normal human fibroblasts.
Assuntos
Proteínas/metabolismo , Sequência de Aminoácidos , Cloreto de Amônio/farmacologia , Animais , Sítios de Ligação , Células CHO , Cricetinae , Endocitose , Fibroblastos/metabolismo , Proteína Ativadora de G(M2) , Gangliosídeo G(M2)/metabolismo , Humanos , Concentração de Íons de Hidrogênio , Hidrólise , Lisossomos/enzimologia , Manosefosfatos/farmacologia , Proteínas/genética , Proteínas Recombinantes de Fusão , Transfecção , beta-N-Acetil-Hexosaminidases/metabolismoRESUMO
The GM2 activator protein is required as a substrate-specific cofactor for beta-hexosaminidase A to hydrolyze GM2 ganglioside. The GM2 activator protein reversibly binds and solubilizes individual GM2 ganglioside molecules, making them available as substrate. Although GM2 ganglioside is the strongest binding ligand for the activator protein, it can also bind and transport between membranes a series of other glycolipids, even at neutral pH. Biosynthetic studies have shown that a large portion of newly synthesized GM2 activator molecules are not targeted to the lysosome, but are secreted and can then be recaptured by other cells through a carbohydrate independent mechanism. Thus, the GM2 activator protein may have other in vivo functions. We found that the GM2 activator protein can inhibit, through specific binding, the ability of platelet activating factor (PAF) to stimulate the release of intracellular Ca2+ pools by human neutrophils. PAF is a biologically potent phosphoacylglycerol. Inhibitors for PAF's role in the pathogenesis of inflammatory bowel disease and asthma have been sought as potential therapeutic agents. The inherent stability and protease resistance of the small, monomeric GM2 activator protein, coupled with the ability to produce large quantities of the functional protein in transformed bacteria, suggest it may serve as such an agent.
Assuntos
Fator de Ativação de Plaquetas/antagonistas & inibidores , Proteínas/metabolismo , Cálcio/metabolismo , Proteína Ativadora de G(M2) , Humanos , Fator de Ativação de Plaquetas/metabolismo , Ligação Proteica , Espectrometria de FluorescênciaRESUMO
In 19 patients with various prostatic diseases, serum and prostatic tissue levels of tobramycin were determined by bioassay and enzyme immunoassay after 1, 3 or 4 intramuscular injections of 75 mg tobramycin. The last injection was given ninety minutes prior to prostatectomy. Mean serum and prostatic tissue levels were respectively 3.55 micrograms/ml and 1.70 micrograms/g by bioassay, and 3.55 micrograms/ml and 2.37 micrograms/g by enzyme immunoassay. There was no significant difference in prostatic tissue levels between patients who received 3 or 4 drug doses and those who received one dose. Prostatic tissue levels were not significantly different in adenoma and chronic prostatitis.
Assuntos
Próstata/metabolismo , Doenças Prostáticas/metabolismo , Tobramicina/metabolismo , Bioensaio , Humanos , Técnicas Imunoenzimáticas , Masculino , Tobramicina/sangueRESUMO
Deficiency of the GM2 activator protein, encoded by GM2A, results in the rare AB-variant form of GM2 gangliosidosis. Four mutations have been identified, but the human gene structure has been only partially characterized. We report a new patient from a Laotian deme whose cells are deficient in both GM2-activator mRNA and protein. However, reverse transcription (RT)-PCR detected some normal-sized cDNA and a smaller cDNA species, which was not seen in the RT-PCR products from normal controls. Sequencing revealed that, although the patient's normal-sized cDNA contained a single nonsense mutation in exon 2, his smaller cDNA was the result of an in-frame deletion of exon 2. Long PCR was used to amplify introns 1 and 2 from patient and normal genomic DNA, and no differences in size, in 5' and 3' end sequences, or in restriction-mapping patterns were observed. From these data we developed a set of four PCR primers that can be used to identify GM2A mutations. We use this procedure to demonstrate that the patient is likely homozygous for the nonsense mutation. Other reports have associated nonsense mutations with dramatically reduced levels of mRNA and with an increased level of skipping of the exon containing the mutation, thus reestablishing an open reading frame. However, a recent article has concluded that, in some cases, the latter observation is caused by an artifact of RT-PCR. In support of this conclusion, we demonstrate that, if the competing, normal-sized cDNA is removed from the initial RT-PCR products, from both patient and normal cells, by an exon 2-specific restriction digest; a second round of PCR produces similar amounts of exon 2-deleted cDNA.
Assuntos
Deleção de Genes , Mutação , Proteínas/genética , Sequência de Bases , Pré-Escolar , Éxons , Proteína Ativadora de G(M2) , Humanos , Íntrons , Masculino , Dados de Sequência Molecular , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Doença de Tay-Sachs/diagnósticoRESUMO
cDNA clones covering a total of 4017 bp were isolated corresponding to the full length of the message for human pyruvate carboxylase. The coding sequence consisted of a stretch of 3534 bp flanked by a 5' untranslated sequence of 82 bp and a 3' untranslated region of 389 bp excluding the poly-A tail. The translated amino acid sequence of 1178 residues contained consensus sequences for the covalent attachment for biotin, the binding of ATP and the binding of the substrate, pyruvate.
Assuntos
Clonagem Molecular , DNA Complementar/genética , Rim/enzimologia , Piruvato Carboxilase/genética , Sequência de Aminoácidos , Sequência de Bases , Sequência Consenso , Sequência Conservada , Humanos , Dados de Sequência Molecular , Reação em Cadeia da Polimerase , Piruvato Carboxilase/químicaRESUMO
Although essential arterial hypertension is believed to have a strong genetic predisposition, the gene(s) responsible are unknown. The mechanisms underlying the regulation of blood pressure and experimental studies place the renin gene among the main candidate genes that need to be tested in humans. We tested the hypothesis of a linkage between the renin gene and essential hypertension using the affected sib pair method. Siblings (133 subjects, 52.1 +/- 10.9 years) from 57 families were selected for sustained hypertension (160.7 +/- 22.9/99.5 +/- 12.8 mmHg with 80% of patients under antihypertensive treatment), of early onset (40.7 +/- 12.0 years), in the absence of obesity, diabetes mellitus, and secondary hypertension. Eight renin haplotypes were generated from three diallelic renin restriction fragment length polymorphisms (RFLPs) (TaqI, HinfI, HindIII) located throughout the renin gene. The allelic concordance between the sib pairs was analyzed by identity by state relationships for 98 sib pairs (41 for 41 couples, 39 for 13 trios, 18 for 3 quartets). Allelic frequencies in the 57 hypertensive probands were similar to those observed among 102 hypertensive subjects studied previously. Six of eight possible haplotypes were observed, the informativity of the marker corresponded to 70% of heterozygosity. Allelic concordance for all sib pairs according to sibship size was not significantly different from that expected under the hypothesis of no linkage (t = 0.52, P = 0.15) reflecting only a small excess of renin alleles shared by the hypertensive sibs (1.44 +/- 0.6 vs 1.36 +/- 0.6). Likewise the linkage hypothesis was unsupported by weighted estimates to correct for possible bias due to large sibship size. Thus, the sib pair analysis suggests that the renin gene does not have a frequent role in the pathogenesis of essential hypertension; further more powerful linkage studies or other approaches will be needed to detect contributions at the renin locus to the heritability of essential hypertension.
Assuntos
Ligação Genética , Haplótipos , Hipertensão/genética , Renina/genética , Alelos , Estudos de Casos e Controles , Família , Genótipo , Humanos , Polimorfismo de Fragmento de Restrição , Mapeamento por RestriçãoRESUMO
The hypothesis of a genetic control of plasma angiotensin I-converting enzyme (ACE) level has been suggested both by segregation analysis and by the identification of an insertion/deletion (I/D) polymorphism of the ACE gene, a polymorphism contributing much to the variability of ACE level. To elucidate whether the I/D polymorphism was directly involved in the genetic regulation, plasma ACE activity and genotype for the I/D polymorphism were both measured in a sample of 98 healthy nuclear families. The pattern of familial correlations of ACE level was compatible with a zero correlation between spouses and equal parent-offspring and sib-sib correlations (.24 +/- .04). A segregation analysis indicated that this familial resemblance could be entirely explained by the transmission of a codominant major gene. The I/D polymorphism was associated with marked differences of ACE levels, although these differences were less pronounced than those observed in the segregation analysis. After adjustment for the polymorphism effects, the residual heritability (.280 +/- .096) was significant. Finally, a combined segregation and linkage analysis provided evidence that the major-gene effect was due to a variant of the ACE gene, in strong linkage disequilibrium with the I/D polymorphism. The marker allele I appeared always associated with the major-gene allele s characterized by lower ACE levels. The frequency of allele I was .431 +/- .025, and that of major allele s was .557 +/- .041. The major gene had codominant effects equal to 1.3 residual SDs and accounted for 44% of the total variability of ACE level, as compared with 28% for the I/D polymorphism.(ABSTRACT TRUNCATED AT 250 WORDS)
Assuntos
Peptidil Dipeptidase A/genética , Adolescente , Adulto , Análise de Variância , Sequência de Bases , Criança , Feminino , Ligação Genética , Variação Genética , Genótipo , Humanos , Desequilíbrio de Ligação , Masculino , Pessoa de Meia-Idade , Dados de Sequência Molecular , Peptidil Dipeptidase A/sangue , Polimorfismo GenéticoRESUMO
The function of the GM2 activator protein is to act as a substrate-specific cofactor in the hydrolysis of GM2 ganglioside by beta-hexosaminidase A. Mutations in the gene encoding it result in the AB variant form of GM2 gangliosidosis. One such mutation, Cys138 Arg, results in the mutant protein being retained and degraded in the endoplasmic reticulum of mammalian cells. In order to characterize the biochemical effects of this substitution, we expressed the mutant protein in transformed bacteria. We first compared the wild-type protein produced by two bacterial expression methods, one requiring protein refolding, with activator purified from the medium of transfected CHO cells. The "activity" and circular dichroism spectrum (alpha-helical content) of all three proteins were similar, justifying the use of refolded activator from transformed bacteria in structure/function studies. Second, the mutant protein was expressed in both bacterial systems and in each retained approximately 2% of the wild type's specific activity. The presence of even this small amount of activity in the mutant protein coupled with a calculated alpha-helical content nearly identical to the wild type, strongly suggest that no major tertiary or secondary structural changes, respectively, had occurred due to the mutation. However, we demonstrate that its heat stability at 60 degrees C is reduced 14-fold, suggesting some localized change in tertiary structure. The loss of a disulfide loop was confirmed by reacting the mutant protein with Ellman's reagent. A kinetic analysis detected a large increase in the apparent K(m) of beta-hexosaminidase A for the mutant; however, there was no apparent change in Vmax. A fluorescence dequenching assay was used to evaluate the ability of the mutant protein to transport lipids and bind GM2 ganglioside. These assays detected no difference between the wild-type and mutant proteins, indicating that the Cys138 Arg substitution has no effect on these functions. We conclude that the mutation specifically affects a domain in the activator protein that is responsible for the recognition of the activator-GM2 ganglioside complex by beta-hexosaminidase A.
Assuntos
Substituição de Aminoácidos/genética , Arginina/genética , Cisteína/genética , Gangliosídeo G(M2)/genética , Gangliosidoses/genética , Proteínas/metabolismo , beta-N-Acetil-Hexosaminidases/metabolismo , Sequência de Aminoácidos , Animais , Células CHO , Cricetinae , Cisteína/fisiologia , Dissulfetos , Escherichia coli/genética , Proteína Ativadora de G(M2) , Gangliosidoses/enzimologia , Variação Genética , Dados de Sequência Molecular , Oligopeptídeos , Peptídeos/genética , Dobramento de Proteína , Proteínas/genética , Proteínas Recombinantes de Fusão/biossínteseRESUMO
Enflurane has been introduced as a potentially useful clinical anesthetic compound. Its administration is followed by elevations of blood and urine concentrations of inorganic fluoride, whose nephrotoxicity has been previously described. Although the action of this element on the skeleton is well documented when ingested orally, its influence has not yet been investigated when it results from the metabolism of fluorinated anesthetic drugs. The present study examines renal function and calcium-phosphorus balance after administration of low concentration of enflurane. Twenty-one patients of both sexes undergoing minor surgery were selected. A statistical analysis of biologic items determined before and after anesthesia showed no significant variations of parameters involved in renal function. On the contrary, it was shown that biodegradation of enflurane was responsible for a significant change in blood and urine phosphorus concentrations. Moreover variations in phosphorus clearance suggested a transitory hypersecretion of parathyroid hormones, probably related to inorganic fluoride metabolism. Such a result is interesting because of the low blood concentration of inorganic fluoride and its transitory character.
Assuntos
Anestesia , Enflurano , Fluoretos/metabolismo , Glândulas Paratireoides/metabolismo , Adulto , Cálcio/metabolismo , Feminino , Meia-Vida , Humanos , Rim/metabolismo , Masculino , Pessoa de Meia-Idade , Fósforo/metabolismo , Fatores de TempoRESUMO
We characterized the pyruvate carboxylase (PC) gene by PCR amplification, subcloning, and sequencing. The coding region has 19 exons and 18 introns spanning approximately 16 kb of genomic DNA. Screening both the cDNA and the gene of individuals with the simple A form of PC deficiency revealed an 1828G-->A missense mutation in 11 Ojibwa and 2 Cree patients and a 2229G-->T transversion mutation in 2 brothers of Micmac origin. Carrier frequency may be as high as 1/10 in some groupings. The two point mutations are located in a region of homology conserved among yeast, rat, and human PC, in the vicinity of the carboxylation domain of the enzyme. These data provide the first characterization of the human PC gene structure, the identification of common pathogenic mutations, and the demonstration of a founder effect in the Ojibwa and Cree patients.